FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Equine veterinary journal2024; 56(6); 1170-1182; doi: 10.1111/evj.14082

A retrospective comparison of postoperative outcomes in ovariectomised jennies (Equus asinus) treated with phenylbutazone or flunixin meglumine.

Abstract: Clinically, flunixin meglumine (FM) and phenylbutazone (PBZ) are preferentially selected for the treatment of visceral and musculoskeletal pain, respectively, in horses. In donkeys, there is no information to support or refute this conventional conjecture. Objective: To compare postoperative outcomes in a group of jennies treated with intravenous FM or oral PBZ. Methods: Fourteen jennies unilaterally ovariectomised by standing left flank laparotomy. Methods: Retrospective cohort study. Methods: Data from medical records of ovariectomised jennies (case details, weight, non-steroidal anti-inflammatory drug [NSAID] protocol, surgery duration, operative sequence, anaesthesia protocol, physical examination findings and outcomes) were collected. From collated data, postoperative adverse events were defined as fever, tachycardia, tachypnea, inappetence, altered mentation, abnormal oral mucous membranes, bruxism, colic, incisional complications (i.e., drainage, oedema, peri-incisional emphysema and pain) and non-survival, then further divided into occurrence during the early (≤24 h) or late (>24 h) postoperative period for data analysis using R software. Chi-squared test was used to compare individual adverse events between groups (PBZ vs. FM) and moments (early vs. late). Significance was set at p ≤ 0.05. Results: PBZ treatment (8/14) was associated with (odds ratio, 95% confidence interval) more total (2.93, 1.97-4.36), early (3.01, 1.87-4.84) and late (2.69, 1.28-5.63) adverse events than FM treatment (6/14). Tachycardia (37.83, 2.21-646.66), tachypnoea (0.29, 0.13-0.66), altered mentation (2.78, 1.01-7.67), altered mucous membranes (18.38, 1.04-325.23), incisional oedema (44.33, 2.60-754.5) and incisional pain (47.78, 2.81-811.61) were significantly different between groups. Early adverse events significantly different between groups included tachycardia (50.2, 2.9-877.0), altered mentation (3.33, 1.08-10.29) and incisional pain (21.0, 1.2-374.5), with late adverse events being tachypnea (0.07, 0.01-0.62), incisional oedema (32.92, 1.85-584.28) and incisional pain (28.92, 1.62-515.68). Colic (2/8) and non-survival (1/8) were rare events that only occurred in the PBZ cohort and could not be further evaluated for differences. Conclusions: Small sample size; retrospective study; treatment bias; varied administration routes. Conclusions: Oral PBZ may be inappropriate to use following abdominal surgery in donkeys. Conclusions: More prospective and case-controlled studies are needed to evaluate the clinical efficacy of these two NSAIDs in donkeys. Unassigned: Klinisch werden Flunixin‐Meglumin (FM) und Phenylbutazon (PBZ) bevorzugt zur Behandlung von viszeralen bzw. muskuloskelettalen Schmerzen bei Pferden eingesetzt. Bei Eseln gibt es keine Informationen, die diese herkömmliche Annahme bestätigen oder widerlegen. Unassigned: Vergleich der postoperativen Ergebnisse in einer Gruppe von Eselstuten, die mit intravenösem FM oder oralem PBZ behandelt wurden. Unassigned: Vierzehn einseitig, durch stehende Laparotomie über der linken Flanke ovarektomierte Eselstuten. Methods: Retrospektive Kohortenstudie. Methods: Es wurden Daten aus den medizinischen Aufzeichnungen ovarektomierter Eselstuten (Signalement, Gewicht, Protokoll für nichtsteroidale entzündungshemmende Medikamente [NSAID], Operationsdauer, Operationsablauf, Anästhesieprotokoll, Ergebnisse der klinischen Allgemeinuntersuchung und Ausgang) gesammelt. Aus den gesammelten Daten wurden postoperative unerwünschte Ereignisse definiert als Fieber, Tachykardie, Tachypnoe, Inappetenz, verändertes Bewusstsein, abnorme Maulschleimhäute, Bruxismus, Kolik, Komplikationen im Bereich der Inzision (d. h. Ausfluss, Ödem, Emphysem im Bereich der Inzision und Schmerzen) und Nichtüberleben. Anschließend wurden die Daten mit Hilfe der Software R nach Auftreten in der frühen (≤24 h) oder späten (>24 h) postoperativen Phase analysiert. Der Chi‐Quadrat‐Test wurde zum Vergleich einzelner unerwünschter Ereignisse zwischen den Gruppen (PBZ vs. FM) und den Zeitpunkten (früh vs. spät) verwendet. Die Signifikanz wurde auf P≤0,05 festgelegt. Unassigned: Die Behandlung mit PBZ (8/14) war mit (odds ratio, 95%CI) mehr insgesamten (2,93; 1,97–4,36), frühen (3,01; 1,87–4,84) und späten (2,69; 1,28–5,63) Komplikationen verbunden als die Behandlung mit FM (6/14). Tachykardie (37,83; 2,21–646,66), Tachypnoe (0,29; 0,13–0,66), verändertes Bewusstsein (2,78; 1,01–7,67), veränderte Maulschleimhaut (18,38; 1,04–325,23), Ödem im Bereich der Inzisionsstelle (44,33; 2,60–754,5) and Schmerz im Bereich der Inzisionsstelle (47,78; 2,81–811,61) unterschieden sich signifikant zwischen den Gruppen. Zu den frühen unerwünschten Ereignissen, die sich zwischen den Gruppen signifikant unterschieden, gehörten Tachykardie (50,2; 2,9‐877,0), Bewusstseinsstörungen (3,33; 1,08‐10,29) und Schmerzen im Inzisionsbereich (21,0; 1,2‐374,5), wobei die späten unerwünschten Ereignisse Tachypnoe (0,07; 0,01‐0,62), Ödeme im Inzisionsbereich (32,92; 1,85‐584,28) und Schmerzen im Inzisionsbereich (28,92; 1,62‐515,68) waren. Koliken (2/8) und Nichtüberleben (1/8) waren seltene Ereignisse, die nur in der PBZ‐Kohorte auftraten und nicht weiter auf Unterschiede untersucht werden konnten. Unassigned: Geringe Stichprobengröße; retrospektive Studie; Behandlungsbias; unterschiedliche Verabreichungswege. Unassigned: Die orale Verabreichung von PBZ ist bei Eseln nach abdominalen Eingriffen möglicherweise nicht geeignet. Es sind weitere prospektive und fallkontrollierte Studien erforderlich, um die klinische Wirksamkeit dieser beiden NSAIDs bei Eseln zu bewerten.
© 2024 EVJ Ltd.
Get Full Text
Publication Date: 2024-03-18 PubMed ID: 38500306DOI: 10.1111/evj.14082Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article compares the postoperative outcomes of female donkeys treated with phenylbutazone (PBZ) and flunixin meglumine (FM), medications commonly used for pain management. The results indicate that PBZ treatment resulted in a higher number of adverse events than FM, implying that PBZ may not be appropriate for use following abdominal surgery in donkeys.

Objective and Methods

  • The main objective of the study was to compare the impact of PBZ and FM on the postoperative outcomes in a group of female donkeys undergoing a surgical procedure known as unilateral ovariectomy via standing left flank laparotomy.
  • This is a retrospective cohort study that involved the analysis of medical records for 14 female donkeys that underwent the said operation.
  • Specific parameters were investigated, including case details, weight, the NSAID treatment protocol, the duration of the surgery, the sequence of the operation, the anaesthesia protocol, physical examination findings, and outcomes.

Data Analysis

  • The study defined postoperative adverse events as fever, tachycardia (rapid heart rate), tachypnea (abnormally rapid breathing), inappetence (lack of appetite), altered mental state, abnormal oral mucous membranes, bruxism (teeth grinding), colic, incisional complications (such as drainage, swelling, peri-incisional emphysema, and pain), and non-survival.
  • Postoperative adverse events were further divided into those that occurred during the early (≤24 hours) or late (>24 hours) postoperative period.
  • The statistical program R was used to compare occurrences between the PBZ and FM treatment groups and between early and late moments using the chi-squared test.

Results and Conclusion

  • PBZ treatment was associated with more total, early, and late adverse events compared to FM treatment.
  • Specifically, significant differences were observed between the groups in terms of tachycardia, tachypnea, altered mentation, incisional oedema, and incisional pain.
  • A noteworthy insight from the study is that colic and non-survival only occurred in the PBZ group.
  • Due to these findings, the authors concluded that PBZ may not be appropriate to use after abdominal surgery in donkeys.
  • However, the authors also recognize the limitations of this study, including its small sample size, retrospective nature, treatment bias, and varied administration routes.
  • More prospective and case-controlled studies are suggested for a comprehensive evaluation of the clinical efficacy of these two NSAIDs in donkeys.

Cite This Article

APA
Xue C, Segabinazzi L, Hall A, Dzikiti TB, French H, Gilbert R. (2024). A retrospective comparison of postoperative outcomes in ovariectomised jennies (Equus asinus) treated with phenylbutazone or flunixin meglumine. Equine Vet J, 56(6), 1170-1182. https://doi.org/10.1111/evj.14082

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 56
Issue: 6
Pages: 1170-1182

Researcher Affiliations

Xue, Cynthia
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, Basseterre, St. Kitts, West Indies.
Segabinazzi, Lorenzo
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, Basseterre, St. Kitts, West Indies.
Hall, Alexis
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, Basseterre, St. Kitts, West Indies.
Dzikiti, Tarisai Brighton
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, Basseterre, St. Kitts, West Indies.
French, Hilari
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, Basseterre, St. Kitts, West Indies.
Gilbert, Robert
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, Basseterre, St. Kitts, West Indies.

MeSH Terms

  • Animals
  • Clonixin / analogs & derivatives
  • Clonixin / therapeutic use
  • Clonixin / administration & dosage
  • Female
  • Retrospective Studies
  • Equidae
  • Ovariectomy / veterinary
  • Ovariectomy / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Phenylbutazone / therapeutic use
  • Phenylbutazone / administration & dosage
  • Pain, Postoperative / veterinary
  • Pain, Postoperative / drug therapy
  • Cohort Studies
  • Postoperative Complications / veterinary
  • Treatment Outcome

Grant Funding

  • Ross University Center for Conservation Medicine and Ecosystem Health

References

This article includes 79 references
  1. Davis JL. Pharmacologic principles. 2018 p. 124–126.
  2. Duz M, Marshall JF, Parkin TD. Proportion of nonsteroidal anti‐inflammatory drug prescription in equine practice. Equine Vet J 2019;51(2):147–153.
    doi: 10.1111/evj.12997google scholar: lookup
  3. Sanchez LC, Robertson SA. Pain control in horses: what do we really know?. Equine Vet J 2014;46(4):517–523.
    doi: 10.1111/evj.12265google scholar: lookup
  4. King JN, Gerring EL. Antagonism of endotoxin‐induced disruption of equine bowel motility by flunixin and phenylbutazone. Equine Vet J 1989;21(S7):38–42.
    doi: 10.1111/j.2042-3306.1989.tb05653.xgoogle scholar: lookup
  5. Lees P, Higgins AJ. Clinical pharmacology and therapeutic uses of non‐steroidal anti‐inflammatory drugs in the horse. Equine Vet J 1985;17(2):83–96.
    doi: 10.1111/j.2042‐3306.1985.tb02056.xgoogle scholar: lookup
  6. Robertson SA, Sanchez LC. Treatment of visceral pain in horses. Vet Clin North Am Equine Pract 2010;26(3):603–617.
    doi: 10.1016/j.cveq.2010.08.002google scholar: lookup
  7. Goodrich LR, Nixon AJ. Medical treatment of osteoarthritis in the horse—a review. Vet J 2006;171(1):51–69.
    doi: 10.1016/j.tvjl.2004.07.008google scholar: lookup
  8. Clark JO, Clark TP. Analgesia. Vet Clin North Am Equine Pract 1999;15(3):705–723.
    doi: 10.1016/s0749-0739(17)30140-2google scholar: lookup
  9. UCVM Class of 2016, Banse H, Cribb AE. Comparative efficacy of oral meloxicam and phenylbutazone in 2 experimental pain models in the horse. Can Vet J 2017;58(2):157–167.
  10. van Weeren PR, de Grauw JC. Pain in osteoarthritis. Vet Clin North Am Equine Pract 2010;26(3):619–642.
    doi: 10.1016/j.cveq.2010.07.007google scholar: lookup
  11. Jacobs CC, Schnabel LV, McIlwraith CW, Blikslager AT. Non‐steroidal anti‐inflammatory drugs in equine orthopaedics. Equine Vet J 2022;54(4):636–648.
    doi: 10.1111/evj.13561google scholar: lookup
  12. Raekallio M, Taylor PM, Bennett RC. Preliminary investigations of pain and analgesia assessment in horses administered phenylbutazone or placebo after arthroscopic surgery. Vet Surg 1997;26(2):150–155.
    doi: 10.1111/j.1532-950x.1997.tb01478.xgoogle scholar: lookup
  13. Bowen IM, Redpath A, Dugdale A, Burford JH, Lloyd D, Watson T. BEVA primary care clinical guidelines: analgesia. Equine Vet J 2020;52(1):13–27.
    doi: 10.1111/evj.13198google scholar: lookup
  14. Edwards GB. Gastroenterology 1. Colic. 2012 p. 21–47.
    doi: 10.1016/b978-0-7020-2801-4.00002-xgoogle scholar: lookup
  15. Makra Z, Csereklye N, Riera MM, McMullen RJ, Veres‐Nyéki K. Effects of intravenous flunixin meglumine, phenylbutazone, and acupuncture on ocular pain scores in the horse: a pilot study. J Equine Vet 2021;98:103375.
    doi: 10.1016/j.jevs.2021.103375google scholar: lookup
  16. Knych HK. Nonsteroidal anti‐inflammatory drug use in horses. Vet Clin North Am Equine Pract 2017;33(1):1–15.
    doi: 10.1016/j.cveq.2016.11.001google scholar: lookup
  17. MacKay RJ, French TW, Nguyen HT, Mayhew IG. Effects of large doses of phenylbutazone administration to horses. Am J Vet Res 1983;44(5):774–780.
  18. Foreman JH, Barange A, Lawrence LM, Hungerford LL. Effects of single‐dose intravenous phenylbutazone on experimentally induced, reversible lameness in the horse. J Vet Pharmacol Ther 2007;31(1):39–44.
    doi: 10.1111/j.1365-2885.2007.00925.xgoogle scholar: lookup
  19. Gibbs R, Duz M, Shipman E. A survey of non‐steroidal anti‐inflammatory drug use in the post‐operative period following equine colic surgery. Equine Vet Educ 2023;35(2):e121–e130.
    doi: 10.1111/eve.13660google scholar: lookup
  20. Hilton HG, Magdesian KG, Groth AD, Knych H, Stanley SD, Hollingsworth SR. Distribution of flunixin meglumine and firocoxib into aqueous humor of horses. J Vet Intern Med 2011;25(5):1127–1133.
    doi: 10.1111/j.1939-1676.2011.0763.xgoogle scholar: lookup
  21. Sprayson T, Thiemann A. Clinical approach to castration in the donkey. In Pract 2007;29(9):526–531.
    doi: 10.1136/inpract.29.9.526google scholar: lookup
  22. Dalla Costa E, Minero M, Lebelt D, Stucke D, Canali E, Leach MC. Development of the Horse Grimace Scale (HGS) as a pain assessment tool in horses undergoing routine castration. PLoS One 2014;9(3):e92281.
    doi: 10.1371/journal.pone.0092281google scholar: lookup
  23. Coakley M, Peck KE, Taylor TS, Matthews NS, Mealey KL. Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses. Am J Vet Res 1999;60(11):1441–1444.
  24. Grosenbaugh DA, Reinemeyer CR, Figueiredo MD. Pharmacology and therapeutics in donkeys. Equine Vet Educ 2011;23(10):523–530.
    doi: 10.1111/j.2042-3292.2011.00291.xgoogle scholar: lookup
  25. Matthews NS, Peck KE, Taylor TS, Mealey KL. Pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in miniature donkeys. Am J Vet Res 2001;62(5):673–675.
    doi: 10.2460/ajvr.2001.62.673google scholar: lookup
  26. Peck K, Mealey KL, Matthews NS, Taylor TS. Comparative pharmacokinetics of caffeine and three metabolites in clinically normal horses and donkeys. Am J Vet Res 1997;58(8):881–884.
  27. Horspool LJI, McKellar QA. Disposition of oxytetracycline in horses, ponies and donkeys after intravenous administration. Equine Vet J 1990;22(4):284–285.
    doi: 10.1111/j.2042-3306.1990.tb04268.xgoogle scholar: lookup
  28. Matthews NS, Peck KE, Mealey KL, Taylor TS, Ray AC. Pharmacokinetics and cardiopulmonary effects of guaifenesin in donkeys. J Vet Pharmacol Ther 1997;20(6):442–446.
    doi: 10.1046/j.1365-2885.1997.00081.xgoogle scholar: lookup
  29. Matthews NS. Anesthetic management of donkeys and mules. 2000.
  30. Matthews NS, Taylors TS. Anesthesia and analgesia for donkeys. 2004.
  31. Mealey KL, Matthews NS, Peck KE, Burchfield ML, Bennett BS, Taylor TS. Pharmacokinetics of R(−) and S(+) carprofen after administration of racemic carprofen in donkeys and horses. Am J Vet Res 2004;65(11):1479–1482.
    doi: 10.2460/ajvr.2004.65.1479google scholar: lookup
  32. Mealey KL, Matthews NS, Peck KE, Ray AC, Taylor TS. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys. Am J Vet Res 1997;58(1):53–55.
  33. Peck KE, Matthews NS, Taylor TS, Mealey KL. Pharmacokinetics of sulfamethoxazole and trimethoprim in donkeys, mules, and horses. Am J Vet Res 2002;63(3):349–353.
    doi: 10.2460/ajvr.2002.63.349google scholar: lookup
  34. Trawford AF. Prescribing for donkeys. 2004 p. 31–33.
  35. Lizarraga I, Sumano H, Brumbaugh GW. Pharmacological and pharmacokinetic differences between donkeys and horses. Equine Vet Educ 2004;16(2):102–112.
    doi: 10.1111/j.2042-3292.2004.tb00275.xgoogle scholar: lookup
  36. Erkert RS, MacAllister CG, Payton ME, Clarke CR. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome. Am J Vet Res 2005;66(2):284–288.
    doi: 10.2460/ajvr.2005.66.284google scholar: lookup
  37. Foreman JH, Grubb TL, Inoue OJ, Banner SE, Ball KT. Efficacy of single‐dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses. Equine Vet J 2010;42:601–605.
    doi: 10.1111/j.2042-3306.2010.00232.xgoogle scholar: lookup
  38. Foreman JH, Ruemmler R. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses. Equine Vet J 2011;43:12–17.
    doi: 10.1111/j.2042-3306.2011.00485.xgoogle scholar: lookup
  39. Ashley FH, Waterman‐Pearson AE, Whay HR. Behavioural assessment of pain in horses and donkeys: application to clinical practice and future studies. Equine Vet J 2005;37(6):565–575.
    doi: 10.2746/042516405775314826google scholar: lookup
  40. Regan FH, Hockenhull J, Pritchard JC, Waterman‐Pearson AE, Whay HR. Behavioural repertoire of working donkeys and consistency of behaviour over time, as a preliminary step towards identifying pain‐related behaviours. PloS One 2014;9(7):e101877.
    doi: 10.1371/journal.pone.0101877google scholar: lookup
  41. van Dierendonck MC, Burden FA, Rickards K, van Loon JPAM. Monitoring acute pain in donkeys with the Equine Utrecht University Scale for Donkeys Composite Pain Assessment (EQUUS‐DONKEY‐COMPASS) and the Equine Utrecht University Scale for Donkey Facial Assessment of Pain (EQUUS‐DONKEY‐FAP). Animals 2020;10(2):354.
    doi: 10.3390/ani10020354google scholar: lookup
  42. de Oliveira MGC, de Paula VV, Mouta AN, de Oliveira Lima I, de Macêdo LB, Nunes TL. Validation of the Donkey Pain Scale (DOPS) for assessing postoperative pain in donkeys. Front Vet Sci 2021;8:671330.
    doi: 10.3389/fvets.2021.671330google scholar: lookup
  43. Orth EK, Navas González FJ, Iglesias Pastrana C, Berger JM, Jeune SS, Davis EW. Development of a donkey grimace scale to recognize pain in donkeys (Equus asinus) post castration. Animals 2020;10(8):1411.
    doi: 10.3390/ani10081411google scholar: lookup
  44. Zinkl JG, Mae D, Guzman Merida P, Farver TB, Humble JA. Reference ranges and the influence of age and sex on hematologic and serum biochemical values in donkeys (Equus asinus). Am J Vet Res 1990;51(3):408–413.
  45. The Donkey Sanctuary. Sedation, anaesthesia and analgesia. 2018 p. 211–227.
  46. The Donkey Sanctuary. Behaviour. 2018 p. 10–22.
  47. The Donkey Sanctuary. The gastrointestinal system. 2018 p. 40–50.
  48. The Donkey Sanctuary. The approach to the dull donkey. 2018 p. 159–171.
  49. Grint NJ, Beths T, Yvorchuk‐St Jean K, Whay HR, Murrell JC. Analysis of behaviors observed during mechanical nociceptive threshold testing in donkeys and horses. J Equine Vet 2017;50:102–109.
    doi: 10.1016/j.jevs.2016.11.001google scholar: lookup
  50. Graubner C, Gerber V, Doherr M, Spadavecchia C. Clinical application and reliability of a Post Abdominal Surgery Pain Assessment Scale (PASPAS) in horses. Vet J 2011;188(2):178–183.
    doi: 10.1016/j.tvjl.2010.04.029google scholar: lookup
  51. Bussières G, Jacques C, Lainay O, Beauchamp G, Leblond A, Cadoré J‐L. Development of a composite orthopaedic pain scale in horses. Res Vet Sci 2008;85(2):294–306.
    doi: 10.1016/j.rvsc.2007.10.011google scholar: lookup
  52. Monteiro BP, Lascelles BDX, Murrell J, Robertson S, Steagall PVM, Wright B. 2022 WSAVA guidelines for the recognition, assessment and treatment of pain. J Small Anim Pract 2023;64(4):177–254.
    doi: 10.1111/jsap.13566google scholar: lookup
  53. Gleerup KB, Lindegaard C. Recognition and quantification of pain in horses: a tutorial review. Equine Vet Educ 2016;28(1):47–57.
    doi: 10.1111/eve.12383google scholar: lookup
  54. Love EJ, Murrell J, Whay HR. Thermal and mechanical nociceptive threshold testing in horses: a review. Vet Anaesth Analg 2011;38(1):3–14.
    doi: 10.1111/j.1467-2995.2010.00580.xgoogle scholar: lookup
  55. Taylor R. Interpretation of the correlation coefficient: a basic review. J Diagn Med Sonogr 1990;6(1):35–39.
    doi: 10.1177/875647939000600106google scholar: lookup
  56. Akoglu H. User's guide to correlation coefficients. Turk J Emerg Med 2018;18(3):91–93.
    doi: 10.1016/j.tjem.2018.08.001google scholar: lookup
  57. The Donkey Sanctuary. Pharmacology and therapeutics. 2018 p. 228–236.
  58. Burden F, Thiemann A. Donkeys are different. J Equine Vet 2015;35(5):376–382.
    doi: 10.1016/j.jevs.2015.03.005google scholar: lookup
  59. Theimann AK, Rickards KJ, Getachew M, Paraschou G. Colic in the donkey. 2017 p. 475–477.
  60. Taylor TS, Matthews NS. Mammoth asses—selected behavioural considerations for the veterinarian. Appl Anim Behav Sci 1998;60(2‐3):283–289.
    doi: 10.1016/s0168-1591(98)00177-4google scholar: lookup
  61. de Oliveira FA, Luna SPL, do Amaral JB, Rodrigues KA, Sant'Anna AC, Daolio M. Validation of the UNESP‐Botucatu unidimensional composite pain scale for assessing postoperative pain in cattle. BMC Vet Res 2014;10(1):200.
    doi: 10.1186/s12917-014-0200-0google scholar: lookup
  62. Taffarel MO, Luna SPL, de Oliveira FA, Cardoso GS, de Moura Alonso J, Pantoja JC. Refinement and partial validation of the UNESP‐Botucatu multidimensional composite pain scale for assessing postoperative pain in horses. BMC Vet Res 2015;11(1):83.
    doi: 10.1186/s12917-015-0395-8google scholar: lookup
  63. de Oliveira MGC, Luna SPL, Nunes TL, Firmino PR, de Lima AGA, Ferreira J. Post‐operative pain behaviour associated with surgical castration in donkeys (Equus asinus). Equine Vet J 2021;53(2):261–266.
    doi: 10.1111/evj.13306google scholar: lookup
  64. Regan Nee Ashley FH, Hockenhull J, Pritchard JC, Waterman‐Pearson AE, Whay HR. Clinical abnormalities in working donkeys and their associations with behaviour. Vet Rec Open 2015;2(1):e000105.
    doi: 10.1136/vetreco-2014-000105google scholar: lookup
  65. Thiemann AK, Sullivan RJE. Gastrointestinal disorders of donkeys and mules. Vet Clin North Am Equine Pract 2019;35(3):419–432.
    doi: 10.1016/j.cveq.2019.08.001google scholar: lookup
  66. Pritchett LC, Ulibarri C, Roberts MC, Schneider RK, Sellon DC. Identification of potential physiological and behavioral indicators of postoperative pain in horses after exploratory celiotomy for colic. Appl Anim Behav Sci 2003;80(1):31–43.
    doi: 10.1016/s0168-1591(02)00205-8google scholar: lookup
  67. Lindegaard C, Vaabengaard D, Christophersen MT, Ekstøm CT, Fjeldborg J. Evaluation of pain and inflammation associated with hot iron branding and microchip transponder injection in horses. Am J Vet Res 2009;70(7):840–847.
    doi: 10.2460/ajvr.70.7.840google scholar: lookup
  68. Olmos G, Alvarado Arellano AQ, du Toit N, Gregory N. A novel approach of pain recognition and assessment in donkey initial results. 2011.
    doi: 10.3921/978-90-8686-737-0google scholar: lookup
  69. Ziegler AL, Freeman CK, Fogle CA, Burke MJ, Davis JL, Cook VL. Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine with firocoxib in horses with small intestinal strangulating obstruction. Equine Vet J 2019;51(3):329–335.
    doi: 10.1111/evj.13013google scholar: lookup
  70. Keegan KG, Messer NT, Reed SK, Wilson DA, Kramer J. Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses. Am J Vet Res 2008;69(2):167–173.
    doi: 10.2460/ajvr.69.2.167google scholar: lookup
  71. Mercer MA, Davis JL, McKenzie HC. The clinical pharmacology and therapeutic evaluation of non‐steroidal anti‐inflammatory drugs in adult horses. Animals 2023;13(10):1597.
    doi: 10.3390/ani13101597google scholar: lookup
  72. Cheng Z, McKellar QA, Nolan A, Lees P. Pharmacokinetics and pharmacodynamics of phenylbutazone and oxyphenbutazone in the donkey. J Vet Pharmacol Ther 1996;19(2):149–151.
    doi: 10.1111/j.1365-2885.1996.tb00028.xgoogle scholar: lookup
  73. Cheng Z, McKellar Q, Nolan A, Lees P. Preliminary pharmacokinetic and pharmacodynamic studies on flunixin meglumine in donkeys. Vet Res Commun 1996;20(5):469–472.
    doi: 10.1007/bf00419184google scholar: lookup
  74. Loesch DA, Rodgerson DH. Surgical approaches to ovariectomy in mares. Compendium Equine 2003;25(11):862–871.
  75. Knych HK, Arthur RM, McKemie DS, Seminoff K, Hamamoto‐Hardman B, Kass PH. Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses. Drug Test Anal 2019;11(6):792–803.
    doi: 10.1002/dta.2553google scholar: lookup
  76. Maitho TE, Lees P, Taylor JB. Absorption and pharmacokinetics of phenylbutazone in Welsh Mountain ponies. J Vet Pharmacol Ther 1986;9(1):26–39.
    doi: 10.1111/j.1365-2885.1986.tb00009.xgoogle scholar: lookup
  77. Bauer AJ, Boeckxstaens GE. Mechanisms of postoperative ileus. Neurogastroenterol Motil 2004;16(s2):54–60.
    doi: 10.1111/j.1743-3150.2004.00558.xgoogle scholar: lookup
  78. Neito J, Rakestraw P. Pathophysiology and treatment of postoperative ileus. 2017 p. 140–148.
  79. Cox R, Proudman CJ, Trawford AF, Burden F, Pinchbeck GL. Epidemiology of impaction colic in donkeys in the UK. BMC Vet Res 2007;3(1):1.
    doi: 10.1186/1746-6148-3-1google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,850 horse owners like you who receive our email updates on horse health and nutrition.